Nuvalent Ownership | Who Owns Nuvalent?

Nuvalent Ownership Summary

Nuvalent is owned by 100.13% institutional investors, 2.74% insiders. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 25.04% of NUVL shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.52% of its assets in Nuvalent shares.

NUVL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Nuvalent	100.13%	2.74%	-2.87%
Sector	Healthcare Stocks	41.89%	10.80%	47.31%
Industry	Biotech Stocks	43.99%	10.76%	45.25%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Deerfield management company, l.p. (series c)	17.99M	25.04%	$1.56B
Fmr	10.01M	13.94%	$865.94M
Paradigm biocapital advisors lp	5.27M	7.33%	$455.70M
Vanguard group	4.61M	6.41%	$398.24M
Blackrock funding, inc. /de	4.09M	5.69%	$353.34M
Blackrock	3.02M	4.71%	$229.37M
Wellington management group llp	2.30M	3.20%	$198.98M
Price t rowe associates inc /md/	1.81M	2.52%	$156.57M
Jpmorgan chase	1.67M	2.33%	$144.77M
State street	1.57M	2.19%	$136.18M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Deerfield management company, l.p. (series c)	17.99M	23.75%	$1.56B
Paradigm biocapital advisors lp	5.27M	12.96%	$455.70M
Commodore capital lp	1.40M	5.91%	$121.07M
Fairmount funds management	727.56K	5.66%	$62.92M
First turn management	394.75K	5.13%	$34.14M
Boxer capital	1.12M	4.48%	$84.98M
Silverarc capital management	372.30K	4.34%	$32.20M
Vestal point capital, lp	1.10M	4.30%	$95.13M
Perceptive advisors	1.56M	3.90%	$135.11M
Affinity asset advisors	384.42K	2.90%	$33.24M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	1.25M	1.33%	1.25M
Wellington management group llp	2.30M	0.03%	724.49K
Jpmorgan chase	1.67M	0.01%	476.82K
Norges bank	318.74K	0.00%	318.74K
Blackrock	3.02M	0.01%	315.17K

Top Sellers

Holder	Shares	% Assets	Change
Bain capital life sciences investors	-	-	-1.45M
Darwin global management	-	-	-1.44M
Logos global management lp	-	-	-500.00K
Samlyn capital	-	-	-309.59K
Deep track capital, lp	-	-	-274.51K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	1.25M	1.33%	1.25M	$107.79M
Norges bank	318.74K	0.00%	318.74K	$24.95M
Connor, clark & lunn investment management	23.79K	0.01%	23.79K	$2.06B
Cantor fitzgerald, l. p.	22.50K	0.02%	22.50K	$1.95M
Bridgewater associates, lp	22.06K	0.01%	22.06K	$1.91M

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Whipplewood advisors	-6.00
Geneos wealth management	-7.00
Stephens consulting	-10.00
Sierra ocean	-13.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	197	-10.05%	71,933,593	0.06%	100	1.00%	98	-20.97%	60	7.14%
Jun 30, 2025	218	1.87%	71,878,154	-0.07%	100	0.99%	123	19.42%	56	-24.32%
Mar 31, 2025	17	-92.58%	31,565,284	-55.28%	44	0.38%	7	-95.17%	7	-85.71%
Dec 31, 2024	226	8.65%	70,521,617	0.93%	107	0.95%	142	17.36%	49	-10.91%
Sep 30, 2024	208	16.85%	69,868,503	6.54%	106	1.02%	122	24.49%	54	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.49M	3.52%	-
Fidelity Growth Compy Commingled Pl S	2.44M	3.38%	3.17K
Fidelity Growth Company Fund	1.72M	2.38%	-10.27K
Vanguard Total Stock Mkt Idx Inv	1.46M	2.03%	-31.09K
Vanguard Small Cap Index	1.13M	1.56%	-7.43K
iShares Russell 2000 ETF	1.04M	1.44%	-
Vanguard Small Cap Value Index Inv	727.18K	1.01%	2.80K
Fidelity Select Health Care	701.80K	0.97%	1.80K
JPMorgan Mid Cap Growth I	649.87K	0.90%	196.81K
Polar Capital Biotech S Inc	625.00K	0.87%	205.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 30, 2025	Noci Darlene	Chief Development Officer	Sell	$119.42K
Oct 30, 2025	Noci Darlene	Chief Development Officer	Sell	$112.47K
Oct 30, 2025	Noci Darlene	Chief Development Officer	Sell	$5.64K
Oct 30, 2025	Noci Darlene	Chief Development Officer	Sell	$35.24K
Oct 30, 2025	Noci Darlene	Chief Development Officer	Sell	$116.09K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	42
2025 Q3	-	32
2025 Q2	-	20
2025 Q1	-	41
2024 Q4	-	33

NUVL Ownership FAQ

Who Owns Nuvalent?

Nuvalent shareholders are primarily institutional investors at 100.12%, followed by 2.74% insiders and -2.87% retail investors. The average institutional ownership in Nuvalent's industry, Biotech Stocks , is 43.99%, which Nuvalent exceeds.

Who owns the most shares of Nuvalent?

Nuvalent’s largest shareholders are Deerfield management company, l.p. (series c) (17.99M shares, 25.04%), Fmr (10.01M shares, 13.94%), and Paradigm biocapital advisors lp (5.27M shares, 7.33%). Together, they hold 46.31% of Nuvalent’s total shares outstanding.

Does Blackrock own Nuvalent?

Yes, BlackRock owns 4.71% of Nuvalent, totaling 3.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 229.37M$. In the last quarter, BlackRock increased its holdings by 315.17K shares, a 11.64% change.

Who is Nuvalent’s biggest shareholder by percentage of total assets invested?

Deerfield management company, l.p. (series c) is Nuvalent’s biggest shareholder by percentage of total assets invested, with 23.75% of its assets in 17.99M Nuvalent shares, valued at 1.56B$.

Who is the top mutual fund holder of Nuvalent shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Nuvalent shares, with 3.52% of its total shares outstanding invested in 2.49M Nuvalent shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools